Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM

Humanized, recombinant IgG1 monoclonal antibody, 400- and 300-mg single-use vials, via intravenous (into the vein) infusion per protocol.

A cereblon E3 ligase modulator, 0.15mg, 0.2mg, 0.3mg, 0.45mg, 0.6, and 0.75 mg strength capsule taken orally per protocol.

Synthetic adrenocortical steroid, 2 and 4 mg tablets, taken orally per standard of care.